@reon1@Watmighthavben appreciate you guys’ contribution and efforts.
Imugene currently has 5 different platforms with several phase1, 1b, 2 and 2b clinical trials running concurrently at lightening speed. The data info flow is so much and certainly not easy for many of us to catch up, least to say fully comprehend. them. Not every is as biotec savvy per se. Ben’s posts have to be sufficiently “long”’ to cover the subjects of discussion but certainly NOT long winded.
We can agree to disagree. Long windedness carries negative connotation. It’s unfair to Ben imho.
Good Luck patients n investors
Kluck
ps. Without bens recent post as reminder I would have missed details of onCARlytics 1st patient dosed
Why IMU is a multi multi bagger, page-20275
-
- There are more pages in this discussion • 4,642 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 5.9¢ | 5.6¢ | $1.037M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1882949 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 399643 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |